WELLINGTON, Fla., Feb. 25 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com) announced today that Noel J. Guillama, President & CEO, will present at the Jesup & Lamont Emerging Growth Stock Conference on Thursday, February 28, 2008, which will be held at the Disney Contemporary Resort in Orlando, Florida.
The presentations will be held in the Grand Republic Ballroom. A breakout session will immediately follow, and management will participate in one-on-one meetings with analysts and investors throughout the day. Mr. Guillama will present on behalf of the company and will be joined at the conference by other members of the Quantum management team.
For more information on the conference contact either your Jesup & Lamont representative or visit http://www.jesuplamontconferences.com.
About The Quantum Group, Inc.
The Quantum Group is a Florida-based organization. The Company builds and manages healthcare systems and offers consulting and outsourcing services that will be leveraged by leading-edge technology to the nation's largest and fastest growing industry -- healthcare.
The Company is engaged in the development and execution of a series of innovative patent-pending technology initiatives designed to make Quantum one of the state's leading providers of business solutions for the healthcare industry. Through its growing number of over 1,800 contracted physicians and managed care relationships in the state of Florida, the Company believes it is positioned to bring increased efficiencies to the Florida healthcare industry.
About Jesup & Lamont
Established in 1877, Jesup & Lamont has an extensive history on Wall Street, with its origins encompassing such successes as providing brokerage services to Standard Oil and raising capital for the construction of Rockefeller Center. Jesup & Lamont is a full service broker-dealer with over 300 retail brokers in over 30 offices nationwide; institutional sales offices in New York, San Francisco, Los Angeles, Boston, Boca Raton and Orlando. The company also publishes proprietary research on several industries including Aerospace/Defense, Alternative Energy and Life Sciences/Healthcare and offers comprehensive investment banking services.
Certain statements contained in this news release, which are not based
on historical facts, are forward-looking statements as the term is defined
in the Private Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the respective
company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K
filings (and amendments thereto) that may cause actual results to
materially differ from projections. Forward-looking statements can be
identified by the use of words such as "expects," "plans," "will," "may,"
"anticipates," "believes," "should," "intends," "estimates" and other words
of similar meaning. These statements are subject to risks and uncertainties
that cannot be predicted or quantified and, consequently, actual results
may differ materially from those expressed or implied by these
forward-looking statements. Such risk factors include, without limitation,
the ability of the Company to properly execute its business model, to raise
substantial and immediate additional capital to implement its business
model, to attract and retain executive, management and operational
personnel, to negotiate favorable current debt and future capital raises,
to negotiate favorable agreements with a diversified provider base and to
continue to supply the services needed by its HMO clients as well physician
clients. The Company does not undertake any obligation to publicly update
any forward-looking statements. There can be no assurance that the
provisional patents discussed in this press release will be granted by the
US Patent and Trademark Office, or, if they are granted, they will not be
challenged by third parties, or if not that we will be able to effectively
use or commercialize such patents and/or we may not have the resources to
deploy such technology. As a result, investors should not place undue
reliance on these forward-looking statements.
FOR MORE INFORMATION, PLEASE CONTACT:
BPC Financial Marketing
Vice President Corporate Communications
The Quantum Group, Inc.
Jesup & Lamont
800.569.3337 x 1160
|SOURCE The Quantum Group, Inc.|
Copyright©2008 PR Newswire.
All rights reserved